Effectiveness and Safety of Upadacitinib in Adolescent and Adult Patients with Atopic Dermatitis: An Analysis of Long-Term (Week 52) Data from a Real-World Multicenter Retrospective Review.

Autor: Rankin BD; Department of Medicine, Division of Dermatology, University of Calgary, Calgary, Canada., Sood S; Temerty Faculty of Medicine, University of Toronto, Toronto, Canada., Park YJ; Temerty Faculty of Medicine, University of Toronto, Toronto, Canada., Rimke A; Dermatology Research Institute, Calgary, Canada., Abduelmula A; Department of Medicine, Division of Dermatology, University of Toronto, Toronto, Canada., Georgakopoulos JR; Department of Medicine, Division of Dermatology, University of Toronto, Toronto, Canada., Maliyar K; Department of Medicine, Division of Dermatology, University of Toronto, Toronto, Canada., Leung F; Dermatology Research Institute, Calgary, Canada.; Skin Health & Wellness Centre, Calgary, Canada., Stark LA; Dermatology Research Institute, Calgary, Canada.; Skin Health & Wellness Centre, Calgary, Canada., Devani AR; Dermatology Research Institute, Calgary, Canada.; Skin Health & Wellness Centre, Calgary, Canada.; Probity Medical Research, Waterloo, Canada., Yeung J; Department of Medicine, Division of Dermatology, University of Toronto, Toronto, Canada.; Probity Medical Research, Waterloo, Canada.; Department of Medicine, Division of Dermatology, Women's College Hospital, Toronto, Canada.; Department of Medicine, Division of Dermatology, Sunnybrook Health Sciences Centre, Toronto, Canada., Prajapati VH; Department of Medicine, Division of Dermatology, University of Calgary, Calgary, Canada.; Dermatology Research Institute, Calgary, Canada.; Skin Health & Wellness Centre, Calgary, Canada.; Probity Medical Research, Waterloo, Canada.; Section of Community Pediatrics, Department of Pediatrics, University of Calgary, Calgary, Canada.; Section of Pediatric Rheumatology, Department of Pediatrics, University of Calgary, Calgary, Canada.

Publikováno v: Dermatitis : contact, atopic, occupational, drug [Dermatitis] 2024 Oct 24. Date of Electronic Publication: 2024 Oct 24.

Effectiveness and Safety of Upadacitinib in Adolescent and Adult Patients with Atopic Dermatitis: An Analysis of Short-Term (Week 8-20) Data from a Real-World Multicenter Retrospective Review.

Autor: Rankin BD; Division of Dermatology, Department of Medicine, University of Calgary, Calgary, Canada., Sood S; Temerty Faculty of Medicine, University of Toronto, Toronto, Canada., Park YJ; Temerty Faculty of Medicine, University of Toronto, Toronto, Canada., Rimke A; Dermatology Research Institute, Calgary, Canada., Abduelmula A; Division of Dermatology, Department of Medicine, University of Toronto, Toronto, Canada., Georgakopoulos JR; Division of Dermatology, Department of Medicine, University of Toronto, Toronto, Canada., Leung F; Dermatology Research Institute, Calgary, Canada.; Skin Health & Wellness Centre, Calgary, Canada., Stark LA; Dermatology Research Institute, Calgary, Canada.; Skin Health & Wellness Centre, Calgary, Canada., Devani AR; Dermatology Research Institute, Calgary, Canada.; Skin Health & Wellness Centre, Calgary, Canada.; Probity Medical Research, Waterloo, Canada., Yeung J; Division of Dermatology, Department of Medicine, University of Toronto, Toronto, Canada.; Probity Medical Research, Waterloo, Canada.; Division of Dermatology, Department of Medicine, Women's College Hospital, Toronto, Canada.; Division of Dermatology, Department of Medicine, Sunnybrook Health Sciences Centre, Toronto, Canada., Prajapati VH; Division of Dermatology, Department of Medicine, University of Calgary, Calgary, Canada.; Dermatology Research Institute, Calgary, Canada.; Skin Health & Wellness Centre, Calgary, Canada.; Probity Medical Research, Waterloo, Canada.; Section of Community Pediatrics, Department of Pediatrics, University of Calgary, Calgary, Canada.; Section of Pediatric Rheumatology, Department of Pediatrics, University of Calgary, Calgary, Canada.

Publikováno v: Dermatitis : contact, atopic, occupational, drug [Dermatitis] 2024 Jun 24. Date of Electronic Publication: 2024 Jun 24.

Once-daily roflumilast foam 0.3% for scalp and body psoriasis: a randomized, double-blind, vehicle-controlled phase IIb study.

Autor: Kircik LH; Icahn School of Medicine at Mount Sinai, New York, NY, USA.; Indiana Medical Center, Indianapolis, IN, USA.; Physicians Skin Care PLLC, Louisville, KY, USA.; Skin Sciences PLLC, Louisville, KY, USA., Alonso-Llamazares J; Driven Research LLC, Coral Gables, FL, USA., Bhatia N; Therapeutics Clinical Research, San Diego, CA, USA., Bukhalo M; Arlington Dermatology, Rolling Meadows, IL, USA., Devani AR; Dermatology Research Institute, Calgary, AB, Canada.; Skin Health and Wellness Centre, Calgary, AB, Canada.; Probity Medical Research, Calgary, AB, Canada., Draelos ZD; Dermatology Consulting Services, High Point, NC, USA., DuBois J; DermResearch Inc., Austin, TX, USA., Gooderham MJ; SkiN Centre for Dermatology, Peterborough, ON, Canada.; Probity Medical Research, Peterborough, ON, Canada.; Queen's University, Peterborough, ON, Canada., Kempers SE; Minnesota Clinical Study Center, Fridley, MN, USA., Lain E; Sanova Dermatology, Austin, TX, USA., Lee M; Progressive Clinical Research, San Antonio, TX, USA., Moore A; Arlington Research Center, Arlington, TX, USA.; Baylor University Medical Center, Dallas, TX, USA., Murrell DF; Faculty of Medicine, University of NSW, Sydney, Australia., Papp KA; Probity Medical Research, Waterloo, ON, Canada.; K. Papp Clinical Research, Waterloo, ON, Canada., Pariser DM; Eastern Virginia Medical School, Norfolk, VA, USA.; Virginia Clinical Research Inc., Norfolk, VA, USA., Sinclair R; Sinclair Dermatology, East Melbourne, Australia., Zirwas M; Dermatologists of the Central States, Probity Medical Research, Bexley, OH, USA.; Ohio University, Bexley, OH, USA., Burnett P; Arcutis Biotherapeutics Inc., Westlake Village, CA, USA., Higham RC; Arcutis Biotherapeutics Inc., Westlake Village, CA, USA., Krupa D; Arcutis Biotherapeutics Inc., Westlake Village, CA, USA., Berk DR; Arcutis Biotherapeutics Inc., Westlake Village, CA, USA.

Publikováno v: The British journal of dermatology [Br J Dermatol] 2023 Sep 15; Vol. 189 (4), pp. 392-399.

Effect of Roflumilast Cream vs Vehicle Cream on Chronic Plaque Psoriasis: The DERMIS-1 and DERMIS-2 Randomized Clinical Trials.

Autor: Lebwohl MG; Icahn School of Medicine at Mount Sinai, New York, New York., Kircik LH; Icahn School of Medicine at Mount Sinai, New York, New York.; Indiana Medical Center, Indianapolis.; Physicians Skin Care PLLC, Louisville, Kentucky.; Skin Sciences PLLC, Louisville, Kentucky., Moore AY; Arlington Research Center, Arlington, Texas.; Baylor University Medical Center, Dallas, Texas., Stein Gold L; Henry Ford Medical Center, Detroit, Michigan., Draelos ZD; Dermatology Consulting Services, High Point, North Carolina., Gooderham MJ; SkiN Centre for Dermatology, Peterborough, Ontario, Canada.; Probity Medical Research, Peterborough, Ontario, Canada.; Queen's University, Peterborough, Ontario, Canada., Papp KA; Probity Medical Research, Waterloo, Ontario, Canada.; K Papp Clinical Research, Waterloo, Ontario, Canada., Bagel J; Psoriasis Treatment Center of Central New Jersey, East Windsor., Bhatia N; Therapeutics Clinical Research, San Diego, California., Del Rosso JQ; JDR Dermatology Research Center LLC, Las Vegas, Nevada.; Advanced Dermatology and Cosmetic Surgery, Maitland, Florida., Ferris LK; University of Pittsburgh Clinical and Translational Science Institute, Pittsburgh, Pennsylvania., Green LJ; George Washington University School of Medicine, Rockville, Maryland., Hebert AA; UT Health McGovern Medical School, Houston, Texas., Jones T; US Dermatology Partners Bryan, Bryan, Texas., Kempers SE; Minnesota Clinical Study Center, Fridley., Pariser DM; Eastern Virginia Medical School, Norfolk.; Virginia Clinical Research Inc, Norfolk., Yamauchi PS; David Geffen School of Medicine at UCLA, Los Angeles, California.; Dermatology Institute and Skin Care Center Inc, Santa Monica, California., Zirwas M; Dermatologists of the Central States, Bexley, Ohio.; Probity Medical Research, Bexley, Ohio.; Ohio University, Bexley, Ohio., Albrecht L; Enverus Medical Research, Surrey, British Columbia, Canada.; Probity Medical Research, Surrey, British Columbia, Canada., Devani AR; Dermatology Research Institute, Calgary, Alberta, Canada.; Probity Medical Research, Calgary, Alberta, Canada., Lomaga M; DermEdge Research, Mississauga, Ontario, Canada.; Probity Medical Research, Mississauga, Ontario, Canada., Feng A; Arcutis Biotherapeutics Inc, Westlake Village, California., Snyder S; Arcutis Biotherapeutics Inc, Westlake Village, California., Burnett P; Arcutis Biotherapeutics Inc, Westlake Village, California., Higham RC; Arcutis Biotherapeutics Inc, Westlake Village, California., Berk DR; Arcutis Biotherapeutics Inc, Westlake Village, California.

Publikováno v: JAMA [JAMA] 2022 Sep 20; Vol. 328 (11), pp. 1073-1084.

Incidence and prognosis of COVID-19 in patients with atopic diseases on dupilumab: a multicentre retrospective cohort study.

Autor: Rankin BD; Cumming School of Medicine, University of Calgary, Calgary, Alberta, Canada., Georgakopoulos JR; Division of Dermatology, Department of Medicine, University of Toronto, Toronto, Ontario, Canada., Sachdeva M; Faculty of Medicine, University of Toronto, Toronto, Ontario, Canada., Mufti A; Division of Dermatology, Department of Medicine, University of Toronto, Toronto, Ontario, Canada., Devani AR; Dermatology Research Institute, Calgary, Alberta, Canada.; Skin Health & Wellness Centre, Calgary, Alberta, Canada.; Probity Medical Research, Calgary, Alberta, Canada., Gooderham MJ; Queen's University, Kingston, Ontario, Canada.; SKiN Centre for Dermatology, Peterborough, Ontario, Canada.; Probity Medical Research, Peterborough, Ontario, Canada., Hong CH; Department of Dermatology and Skin Science, University of British Columbia, Vancouver, British Columbia, Canada.; Dr. Chih-Ho Hong Medical Inc, Surrey, British Columbia, Canada., Jain V; Division of Clinical Immunology and Allergy, McMaster University, Hamilton, Ontario, Canada.; Niagara Region Medical, Niagara Falls, Ontario, Canada.; Allergy Research Canada Inc, Niagara Falls, Ontario, Canada.; Probity Medical Research, Niagara Falls, Ontario, Canada., Lansang P; Division of Dermatology, Department of Medicine, University of Toronto, Toronto, Ontario, Canada.; Division of Dermatology, Department of Medicine, Sunnybrook Health Sciences Centre, Toronto, Ontario, Canada.; Section of Paediatric Dermatology, Department of Paediatric Medicine, The Hospital for Sick Children, Toronto, Ontario, Canada., Vender R; Department of Dermatology, McMaster University, Hamilton, Ontario, Canada.; Dermatrials Research Inc. & Venderm Innovations in Psoriasis, Hamilton, Ontario, Canada., Yeung J; Division of Dermatology, Department of Medicine, University of Toronto, Toronto, Ontario, Canada.; Division of Dermatology, Department of Medicine, Sunnybrook Health Sciences Centre, Toronto, Ontario, Canada.; Section of Paediatric Dermatology, Department of Paediatric Medicine, The Hospital for Sick Children, Toronto, Ontario, Canada.; Probity Medical Research Inc, Waterloo, Ontario, Canada., Prajapati VH; Dermatology Research Institute, Calgary, Alberta, Canada.; Skin Health & Wellness Centre, Calgary, Alberta, Canada.; Probity Medical Research, Calgary, Alberta, Canada.; Division of Dermatology, Department of Medicine, University of Calgary, Calgary, Alberta, Canada.; Section of Community Pediatrics, Department of Pediatrics, University of Calgary, Calgary, Alberta, Canada.; Section of Pediatric Rheumatology, Department of Pediatrics, University of Calgary, Calgary, Alberta, Canada.

Publikováno v: The Journal of dermatological treatment [J Dermatolog Treat] 2022 Aug; Vol. 33 (5), pp. 2692-2694. Date of Electronic Publication: 2022 Apr 21.